Who cares about pharmacovigilance?

被引：25

作者：

Edwards, IR

机构：

[1] Uppsala Monitoring Centre,

[2] The WHO Collaborating Centre for International Drug Monitoring,undefined

[3] Box 26 5-751 03 Uppsala,undefined

[4] Sweden,undefined

来源：

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY | 1997年 / 53卷 / 02期

关键词：

pharmacovigilance; drug safety;

D O I：

10.1007/s002280050342

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：83 / 88

页数：6

共 13 条

[1]

BATEMAN DN, 1992, BRIT J CLIN PHARMACO, V34, P421

[2] ATTITUDINAL SURVEY OF ADVERSE DRUG REACTION REPORTING BY MEDICAL PRACTITIONERS IN THE UNITED-KINGDOM [J].

BELTON, KJ ;

LEWIS, SC ;

PAYNE, S ;

RAWLINS, MD ;

WOOD, SM .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1995, 39 (03) :223-226

[3]

Biriell C, 1997, PHARMACOEPIDEM DR S, V6, P21

[4] ADVERSE DRUG REACTION REPORTING AND RETROSPECTIVE PHENOTYPING FOR OXIDATION POLYMORPHISM [J].

CLARK, DWJ ;

EDWARDS, IR .

MEDICAL TOXICOLOGY AND ADVERSE DRUG EXPERIENCE, 1988, 3 (03) :241-247

[5]

COUTER DM, 1986, MONITORING DRUG SAFE, P119

[6] Concepts in risk-benefit assessment - A simple merit analysis of a medicine? [J].

Edwards, IR ;

Wiholm, BE ;

Martinez, C .

DRUG SAFETY, 1996, 15 (01) :1-7

[7]

Inman W, 1976, EPIDEMIOLOGICAL ISSU

[8]

INMAN WHW, 1986, MONITORING DRUG SAFE, P213

[9] FACTORS DETERMINING PHYSICIAN REPORTING OF ADVERSE DRUG REACTIONS - COMPARISON OF 2000 SPONTANEOUS REPORTS WITH SURVEILLANCE STUDIES AT MASSACHUSETTS GENERAL HOSPITAL [J].

KOCHWESE.J ;

SIDEL, VW ;

SWEET, RH ;

KANAREK, P ;

EATON, AE .

NEW ENGLAND JOURNAL OF MEDICINE, 1969, 280 (01) :20-&

[10]

Lindquist M, 1996, Pharmacoepidemiol Drug Saf, V5, P27, DOI 10.1002/(SICI)1099-1557(199601)5:1<27::AID-PDS199>3.3.CO

← 1 2 →